To better understand: 1) experiences with episodic migraine and effect on daily life; 2) typical pathway and barriers to diagnosis and treatment; and 3) satisfaction levels with current treatments and to identify unmet needs.

Of 50 participants, 75% were female, 64% were aged 30-49 years, and 56% suffered from 3-5 migraines (or 4-8 migraine-days) a month. The two most common occurrences of migraines reported were rapid-onset (34%) and early morning (30%). Although 96% took a prescription medication, only 30% were satisfied with their medication. Incomplete, unreliable and short-lasting relief were the biggest problems. Lack of speed to onset of effect was also a point of dissatisfaction with >50% reporting inability to resume normal activities within 4 hours after medicating. Up to 68% reported headache relief lasting less than 12 hours and pain returning or worsening afterwards. Further, 30% respondents had to seek emergency migraine care in the past year despite access to standard of care. Thus, the social, societal and economic burden of episodic migraine significantly impacts the daily lives and livelihoods of patients with migraine.